Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Queensland Health
US Army
Cantor Fitzgerald

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022110

« Back to Dashboard

NDA 022110 describes VIBATIV, which is a drug marketed by Theravance Biopharma and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug. Additional details are available on the VIBATIV profile page.

The generic ingredient in VIBATIV is telavancin hydrochloride. Two suppliers are listed for this compound. Additional details are available on the telavancin hydrochloride profile page.

Summary for 022110

Formulation / Manufacturing:see details

Pharmacology for NDA: 022110


Suppliers and Packaging for NDA: 022110

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110 NDA Theravance, Inc. 52118-001 52118-001-01 1 VIAL, SINGLE-USE in 1 CONTAINER (52118-001-01) > 50 mL in 1 VIAL, SINGLE-USE
VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110 NDA Theravance, Inc. 52118-002 52118-002-01 1 VIAL, SINGLE-USE in 1 CONTAINER (52118-002-01) > 17 mL in 1 VIAL, SINGLE-USE

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;IV (INFUSION)StrengthEQ 250MG BASE/VIAL
Approval Date:Sep 11, 2009TE:RLD:Yes
Patent:► SubscribePatent Expiration:Sep 11, 2023Product Flag?YSubstance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Aug 24, 2022Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Jun 5, 2021Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim
Chinese Patent Office
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: